Ausdal Financial Partners, Inc. - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 60 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ausdal Financial Partners, Inc. ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$5,000
+25.0%
26,000
+62.5%
0.00%0.0%
Q2 2022$4,000
-20.0%
16,0000.0%0.00%0.0%
Q1 2022$5,000
-44.4%
16,0000.0%0.00%0.0%
Q4 2021$9,000
-43.8%
16,0000.0%0.00%
-50.0%
Q3 2021$16,000
-27.3%
16,0000.0%0.00%
-33.3%
Q2 2021$22,000
-18.5%
16,0000.0%0.00%
-40.0%
Q1 2021$27,000
+35.0%
16,0000.0%0.01%
+25.0%
Q4 2020$20,000
-13.0%
16,0000.0%0.00%
-33.3%
Q3 2020$23,000
+76.9%
16,000
+45.5%
0.01%
+50.0%
Q2 2020$13,000
-38.1%
11,000
-26.7%
0.00%
-42.9%
Q1 2020$21,000
-22.2%
15,000
-3.8%
0.01%
-12.5%
Q4 2019$27,000
-37.2%
15,600
-20.5%
0.01%
-46.7%
Q3 2019$43,000
-18.9%
19,6300.0%0.02%
-25.0%
Q2 2019$53,000
-22.1%
19,6300.0%0.02%
-28.6%
Q1 2019$68,000
+51.1%
19,6300.0%0.03%
+27.3%
Q4 2018$45,000
-41.6%
19,630
-1.4%
0.02%0.0%
Q3 2018$77,000
+16.7%
19,900
+1.6%
0.02%
+10.0%
Q2 2018$66,00019,590
+97850.0%
0.02%
Q4 2015$0200.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Perceptive Advisors 6,574,060$27,874,0001.68%
SENZAR ASSET MANAGEMENT, LLC 798,381$3,385,0000.58%
Cormorant Asset Management, LP 850,000$3,604,0000.48%
Palo Alto Investors LP 2,135,739$9,056,0000.40%
Opus Point Partners Management, LLC 99,959$424,0000.34%
Granahan Investment Management 1,582,237$6,709,0000.19%
Joel Isaacson & Co., LLC 70,660$300,0000.08%
MARINER INVESTMENT GROUP LLC 59,700$253,0000.06%
MYCIO WEALTH PARTNERS, LLC 75,000$318,0000.06%
Cornerstone Capital, Inc. 59,200$251,0000.06%
View complete list of ACELRX PHARMACEUTICALS INC shareholders